×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PALI – palisade bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PALI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
08:35 am
pali
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board [Yahoo! Finance]
Medium
Report
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board [Yahoo! Finance]
12/17
08:30 am
pali
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board
Medium
Report
Palisade Bio Appoints Brian Feagan, MD, FRCPC, to its Clinical Advisory Board
12/13
04:18 pm
pali
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules [Yahoo! Finance]
High
Report
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules [Yahoo! Finance]
12/13
04:05 pm
pali
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Medium
Report
Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
12/12
12:05 pm
pali
Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Medium
Report
Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
12/3
08:15 am
pali
Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects
High
Report
Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects
11/21
08:20 am
pali
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) [Yahoo! Finance]
Medium
Report
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC) [Yahoo! Finance]
11/21
08:15 am
pali
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC)
Low
Report
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic Pathways of Crohn's Disease and Ulcerative Colitis (UC)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/17
05:30 pm
pali
Form 424B3 PALISADE BIO, INC.
Medium
Report
Form 424B3 PALISADE BIO, INC.
12/17
05:30 pm
pali
Form 424B3 PALISADE BIO, INC.
Medium
Report
Form 424B3 PALISADE BIO, INC.
12/17
05:30 pm
pali
Form 424B3 PALISADE BIO, INC.
Medium
Report
Form 424B3 PALISADE BIO, INC.
12/17
06:02 am
pali
Form EFFECT PALISADE BIO, INC.
Medium
Report
Form EFFECT PALISADE BIO, INC.
12/16
04:00 pm
pali
Form 8-K PALISADE BIO, INC. For: Dec 16
Medium
Report
Form 8-K PALISADE BIO, INC. For: Dec 16
12/13
09:58 am
pali
Form POS AM PALISADE BIO, INC.
High
Report
Form POS AM PALISADE BIO, INC.
12/13
06:03 am
pali
Form EFFECT PALISADE BIO, INC.
High
Report
Form EFFECT PALISADE BIO, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: